Inspiratory Profiles Through Easyhaler Dry Powder Inhaler During Acute Bronchoconstriction
<b><i>Background:</i></b> Dry powder inhalers (DPIs) are passive devices, which rely on a patient's inspiratory effort for drug dispersion and delivery. The aim of this study was to assess how acute bronchoconstriction affects the ability to use Easyhaler DPI in adults. <b><i>Methods:</i></b> This study was conducted as part of a parallel-group clinical trial assessing use of Salbutamol Easyhaler, Budesonide-formoterol Easyhaler and salbutamol pMDI with spacer during a methacholine challenge (MC) test. The inhalations through both Easyhaler variants, the inhaler for the single active substance product (EH-mono) and the inhaler for the combination product (EH-combi), were recorded at baseline and during bronchoconstriction. Peak inspiratory flow (PIF), flow rate acceleration and inhalation volume after PIF were compared to the criteria for successful inhalation. <b><i>Results:</i></b> The study population consisted of 120 adult subjects indicated for MC as a diagnostic test for asthma, with 60 subjects in both Easyhaler arms. With EH-combi 98.3% and 91.4% passed the criteria (PIF ≥30 L/min, inhalation acceleration ≥0.7 L/s<sup>2</sup>, and inhalation volume ≥500 mL after PIF) for successful inhalation at baseline and during bronchoconstriction, respectively. With EH-mono, success rates were 95.0% and 88.1% at baseline and during bronchoconstriction, respectively. The most common reason for not passing the criteria was slow inhalation acceleration. Aside from two subjects using EH-mono during bronchoconstriction, all subjects were able to generate PIF ≥ 30 L/min. <b><i>Conclusions:</i></b> During an acute obstructive event, the vast majority of patients have no difficulty in achieving sufficient PIF, inhalation acceleration, and volume after PIF when using an Easyhaler DPI.
Authors
- Jussi Karjalainen (ORCID: https://orcid.org/0000-0001-8747-7087)
- Mikko Vahteristo (ORCID: https://orcid.org/0000-0001-9388-3997)
- Ville A. Vartiainen (ORCID: https://orcid.org/0000-0002-9833-6965)
- L. Pekka Malmberg (ORCID: https://orcid.org/0000-0001-5087-1160)
- Satu Lähelmä (ORCID: https://orcid.org/0000-0002-3189-8584)
- Lauri Lehtimäki (ORCID: https://orcid.org/0000-0003-1586-4998)
- Antti Tikkakoski
- Liisa Vuotari
- Ulla Sairanen
Institutions
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Orion Corporation (Finland) (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
Publication Details
- Journal
- Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1089/jamp.2024.0045
- Citations
- 1
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.52